Results

Total Results: 1,269 records

Showing results for "author year description".

1141. Assessing Applicability (ppt file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/assessing-applicability.ppt
      January 01, 2009 - ACE inhibitor use, 34%; ß-blocker use, 40%) Hospitali-zations and survival Median followup at 1 year … Applicability Summary Table Template Domain Description of Applicability Evidence for a Key Question … Completed Applicability Summary Table Domain Description of Applicability Evidence for a Key Question … DOI: 10.1503/cmaj.090523 References Author This presentation was prepared by C. … Author

1142. Disposition of Comments Report for Intravascular Diagnostic Procedures and Imaging Techniques Versus Angiography Alone in Coronary Artery Stenting (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/coronary-artery-stenting_disposition-comments.pdf
      February 26, 2013 - by approximately 30%, and reduced mortality and myocardial infarction at one year by approximately … February 26, 2013 15 Commentator & Affiliation Section Comment Response procedure and at one year … a functionally non-significant stenosis (as evidenced by a negative FFR test) is less than 1% per year … More recently, Nam et al showed that the one-year clinical outcomes after DES implantation correlated … The FAME five-year data will provide additional valuable insight into the long-term outcomes

1143. Layout 1 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/antipsychotics-children_executive.pdf
      February 01, 2012 - Data Analysis We presented evidence tables and a qualitative description of results for all studies. … Results Description of Included Studies The search strategy identified 10,745 citations. … Psychotropic practice patterns for youth: a 10-year perspective.

1144. AHRQ Slide Template 2009 (ppt file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/data-extraction.ppt
      January 01, 2009 - interpretation of published data is needed (i.e., the extractor must be able to understand what the author … A very common occurrence pertains to the description of statistical methods in observational studies.

1145. Antipsychotics-Children Research-Protocol (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antipsychotics-children_research-protocol.pdf
      June 04, 2010 - The following data will be extracted from each study: author identification, year of publication, source … Adverse events will be recorded for each intervention group including the description of the adverse … Psychotropic practice patterns for youth: a 10-year perspective. … Second generation antipsychotics: FDA status Drug FDA status (year approved) Indications Age group … Second generation antipsychotics: FDA status (continued) Drug FDA status (year approved) Indications

1146. Calcineurin_Inhibitors_Protocol_FINAL_10-07-2014 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/calcineurin-inhibitor_research-protocol.pdf
      October 08, 2014 - Background and Objectives for the Systematic Review Approximately 17,000 kidney transplants occur each year … conditional graft half-life (defined as the time to when half of the grafts surviving at least one year … ), and long-term follow up (more than 1 year). … ) for tacrolimus, and report on at least one analytical or patient-oriented clinical outcome (see description … of PICOTS in the background section for a description of outcomes).

1147. psychiatric-readmissions-protocols-140904 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/psychiatric-readmissions_research-protocol.pdf
      December 31, 2014 - .5 A decrease in number of psychiatric admissions, typically measured over 30 days, 90 days, or 1 year … Specifically, our responses to GQs 1 (description of core components for management strategies to reduce … The following information will be obtained from each study, where applicable: author; year of publication … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description

1148. Title (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/mental-illness-adults-prisons_research-protocol.pdf
      September 13, 2012 - typically provide pretrial detention and short-term confinement after sentencing (generally, less than one year … Prisons, which are correctional facilities that hold sentenced inmates for more than a year, are operated … disorder, or major depression or, in cases where the diagnoses are not clearly presented, the study author … Publication Type • Study must provide a sufficient description of the treatment provided (e.g., duration … Author, publication year, country, setting (rural or urban, as well as jail, prison, forensic hospital

1149. Disposition of Comments for Psychological Treatments and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD) (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ptsd-adult-treatment_disposition-comments.pdf
      April 03, 2013 - So, for the consideration of the author(s): See below for responses to the comments related to methods … We have revised and expanded the description of BEP to clarify. … Unfortunately, the introductory description of EMDR therapy is inaccurate. … So, for the consideration of the author(s): For statistics like time to remission, time to return to … must be stated, e.g., whether or not remission occurs within 6 months of diagnosis or 3 months or 1 year

1150. Presentation of Future Research Needs (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/presentations-future_research.pdf
      April 01, 2012 - The findings and conclusions in this document are those of the author(s), who are responsible for its … Like the description of the future research need, the detail for these research design considerations … Provide succinct yet adequate description of methods and results following guidelines for reporting … Level of detail of FRN description depends on the state of the science. … Provide text description of why the prioritized questions are particularly urgent to be answered.

1151. S44 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/s44.pdf
      October 01, 2007 - I heard they had decided on the 10 biggest hospitals getting funded 1 year, and the next year the next … 10, and the next year the next 10. … The scientific panel recommended a 1-year delay. … Our focus groups with clinicians revealed some discomfort with a delay of 1 year. … PharmaCare found the simplicity of the description very helpful.

1152. women-hiv-protocol-160301 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/women-hiv_research-protocol.pdf
      March 01, 2016 - limit results to studies published after 01/01/2005, published in English, and having at least one author … months to be fully indexed, we will search using only free text terms for studies published in the last year

1153. Renal-Function Research-Protocol (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/renal-function_research-protocol.pdf
      June 13, 2013 - Smoking status j. 10-year coronary heart disease (CHD) risk k. History of CAD 3. … Smoking status j. 10-year coronary heart disease (CHD) risk k. … Smoking status j. 10-year CHD risk k. History of CAD 4. … These studies adhered to the commonly held concepts of high quality, including the following: a clear description … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description

1154. Disposition of Comments for Screening of Methicillin-Resistant Staphylococcus Aureus (MRSA) (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mrsa-screening-2010_disposition-comments.pdf
      January 01, 2010 - In addition, we have provided an example of an expanded and limited screening strategy in the description … Beyond that, the Robiscek paper had moderately more rigorous statistical methodology and a better description … invasive MRSA infections in the population and 25% reduction in MRSA bacteremia in hospitals over a 5-year … Each article included in their analysis is discussed in detail, with a description of the quality of

1155. Template for Reports Developed (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-topic-nomination_methods.pdf
      November 01, 2012 - The Cover Sheet, typically seven to eight pages long, includes a description of the nomination, background … Cover Sheet The Cover Sheet includes a description of the nomination, comprising a summary of the … 13 Summary of nomination’s fit with appropriateness and importance criteria Disease burden Description … and a link to sign up for notification when Key Questions are posted for public comment Topic description

1156. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/autism-adolescents_research-protocol.pdf
      March 29, 2011 - participant characteristics (age, diagnosis, symptom severity, etc.), intervention characteristics (description … evidence table may vary by KQ as appropriate, but the tables will contain some common elements, such as author … , year of publication, study location (e.g., country, city, state) and time period, population description … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description

1157. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/progestogens-preterm-birth_research-protocol.pdf
      June 01, 2010 - annually, and is projected to reduce initial neonatal medical costs by more than $505 million each year … table will vary according to Key Question, but the Tables will contain some common elements (e.g., author … , publication year, study location, time period, population description, sample size, and study type … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description

1158. Disparities-Quality-Improvement Executive (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/disparities-quality-improvement_executive.pdf
      August 01, 2012 - Summary of effects on disparities in health outcomes associated with race or ethnicity Author, Year … Summary of effects on disparities in health outcomes associated with insurance status Author, Year, … Summary of effects on disparities in health outcomes associated with socioeconomic status Author, Year … Summary of effects on disparities in health outcomes associated with sex Author, Year, Study Design … Duration of studies was generally 1 year.

1159. Liver-Cancer-Therapy Executive (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/liver-cancer-therapy_executive.pdf
      May 01, 2013 - is the fifth most common cancer and the third leading cause of cancer death worldwide.1 Overall 5-year … In the other RCT, 3-year cancer- free survival was 43%, 21%, and 23% in the RFA, PEI, and PAI groups … and 42.5% at 2 years for TACE, and 69.8% at 1 year and 58.8% at 2 years for TEA; p = 0.0588). … The clinical heterogeneity was most evident in the description of patient and tumor characteristics … Full description of the patient population is important, as those with, for example, higher ECOG score

1160. Survey of Medicare Part D Plans’ Medication Therapy Management Programs (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/medication-therapy-management-1_research-2007.pdf
      January 01, 2007 - ..............................................................................................13 Author … To the best of our knowledge, this analysis is the first description of MTM programs developed as part … A four-year analysis of an ambulatory care model. Arch Intern Med 1984;144(6):1159-62. 14. … Improving adherence and persistence: a review and assessment of interventions and description of steps … How often does the plan provide for MTM services (e.g., annually, twice a year, quarterly)? 8.